Aluminum-induced defective mitochondrial metabolism perturbs cytoskeletal dynamics in human astrocytoma cells

Journal of Neuroscience Research

Volumn 87, Issue 6, 2009, Pages 1474-1483

  Lemire, J ^a   Mailloux, R ^a   Puiseux Dao, S ^b   Appanna, V D ^a  

^a LAURENTIAN UNIVERSITY   (Canada)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

Aluminum; Astrocytes; ATP; Creatine kinase; Cytoskeletal dynamics; Energy metabolism

Indexed keywords

2 OXOGLUTARIC ACID; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ALUMINUM; CREATINE KINASE; PROFILIN; ALPHA-KETOGLUTARIC ACID; ANTIOXIDANT;

ARTICLE; ASTROCYTOMA CELL; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; NERVE CELL LESION; NEUROLOGIC DISEASE; NEUROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; ASTROCYTE; DRUG EFFECT; FLUORESCENCE MICROSCOPY; IMMUNOBLOTTING; METABOLISM; MITOCHONDRION; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR CELL LINE;

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ALUMINUM; ANTIOXIDANTS; ASTROCYTES; CELL LINE, TUMOR; CREATINE KINASE; CYTOSKELETON; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOBLOTTING; KETOGLUTARIC ACIDS; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; PROFILINS;

EID: 65549169139     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21965     Document Type: Article

References (39)

1. Ackermann M, Matus A. 2003. Activity-induced targeting of profilin and stabilization of dendritic spine morphology. Nat Neurosci 6:1194-1200.
2. Ames A 3rd. 2000. CNS energy metabolism as related to function. Brain Res Brain Res Rev 34:42-68.
3. Anderson CM, Nedergaard M. 2003. Astrocyte-mediated control of cerebral microcirculation. Trends Neurosci 26:340-344.
4. Anderson CM, Swanson RA. 2000. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32:1-14.
5. Aremu DA, Meshitsuka S. 2006. Some aspects of astroglial functions and aluminum implications for neurodegeneration. Brain Res Rev 52:193-200.
6. Becaria A, Campbell A, Bondy SC. 2002. Aluminum as a toxicant. Toxicol Ind Health 18:309-320.
7. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
8. Clarkson MR, Murphy M, Gupta S, Lambe T, Mackenzie HS, Godson C, Martin F, Brady HR. 2002. High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly. J Biol Chem 277:9707-9712.
9. Derouiche A, Anlauf E, Aumann G, Muhlstadt B, Lavialle M. 2002. Anatomical aspects of glia-synapse interaction: the perisynaptic glial sheath consists of a specialized astrocyte compartment. J Physiol Paris 96:177-182.
10. Dzeja PP, Terzic A. 2003. Phosphotransfer networks and cellular energetics. J Exp Biol 206(Pt 12):2039-2047.
11. Fink MP. 2002. Bench-to-bedside review: cytopathic hypoxia. Critical Care 6:491-499.
12. Gartlon J, Kinsner A, Bal-Price A, Coecke S, Clothier RH. 2006. Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. Toxicol In Vitro 20:1569-1581.
13. Gibson GE, Park LC, Sheu KF, Blass JP, Calingasan NY. 2000. The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int 36:97-112.
14. Gourlay CW, Ayscough KR. 2005. The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 6:583-589.
15. Kovar DR, Harris ES, Mahaffy R, Higgs HN, Pollard TD. 2006. Control of the assembly of ATP- and ADP-actin by formins and profilin. Cell 124:423-435.
16. Kraft T, Hornemann T, Stolz M, Nier V, Wallimann T. 2000. Coupling of creatine kinase to glycolytic enzymes at the sarcomeric I-band of skeletal muscle: a biochemical study in situ. J Muscle Res Cell Motil 21:691-703.
17. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680-685.
18. Leach RM, Hill HS, Snetkov VA, Ward JP. 2002. Hypoxia, energy state and pulmonary vasomotor tone. Respir Physiol Neurobiol 132:55-67.
19. Lemire J, Mailloux RJ, Appanna VD. 2008. Mitochondrial lactate dehydrogenase is involved in oxidative-energy metabolism in human astrocytoma cells (CCF-STTG1). PLoS ONE 3:e1550.
20. Mailloux R, Lemire J, Appanna V. 2007a. Aluminum-induced mitochondrial dysfunction leads to lipid accumulation in human hepatocytes: a link to obesity. Cell Physiol Biochem 20:627-638.
21. Mailloux RJ, Beriault R, Lemire J, Singh R, Chenier DR, Hamel RD, Appanna VD. 2007b. The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS ONE 2:e690.
22. Mailloux RJ, Darwich R, Lemire J, Appanna V. 2008. The monitoring of nucleotide diphosphate kinase activity by blue native polyacrylamide gel electrophoresis. Electrophoresis 29:1484-1489.
23. Mentz S, de Lacalle S, Baerga-Ortiz A, Knauer MF, Knauer DJ, Komives EA. 1999. Mechanism of thrombin clearance by human astrocytoma cells. J Neurochem 72:980-987.
24. Oshiro S, Kawahara M, Kuroda Y, Zhang C, Cai Y, Kitajima S, Shirao M. 2000. Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells. Biochim Biophys Acta 1502:405-414.
25. Paavilainen VO, Bertling E, Falck S, Lappalainen P. 2004. Regulation of cytoskeletal dynamics by actin-monomer-binding proteins. Trends Cell Biol 14:386-394.
26. Pekny M, Nilsson M. 2005. Astrocyte activation and reactive gliosis. Glia 50:427-434.
27. Pessoa-Pureur R, Wajner M. 2007. Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies. J Inherit Metab Dis 30:664-672.
28. Rutka JT, Murakami M, Dirks PB, Hubbard SL, Becker LE, Fukuyama K, Jung S, Tsugu A, Matsuzawa K. 1997. Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 87:420-430.
29. Saks VA, Ventura-Clapier R, Aliev MK. 1996. Metabolic control and metabolic capacity: two aspects of creatine kinase functioning in the cells. Biochim Biophys Acta 1274:81-88.
30. Sauer U, Schlattner U. 2004. Inverse metabolic engineering with phosphagen kinase systems improves the cellular energy state. Metab Eng 6:220-228.
31. Schagger H, von Jagow G. 1991. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199:223-231.
32. Singh R, Mailloux RJ, Puiseux-Dao S, Appanna VD. 2007. Oxidative stress evokes a metabolic adaptation that favors increased NADPH synthesis and decreased NADH production in Pseudomonas fluorescens. J Bacteriol 189:6665-6675.
33. Suarez-Fernandez MB, Soldado AB, Sanz-Medel A, Vega JA, Novelli A, Fernandez-Sanchez MT. 1999. Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res 835:125-136.
34. Ting KK, Brew B, Guillemin G. 2007. The involvement of astrocytes and kynurenine pathway in Alzheimer's disease. Neurotox Res 12:247-262.
35. Tsuji T, Shimohama S. 2001. Analysis of the proteomic profiling of brain tissue in Alzheimer's disease. Dis Markers 17:247-257.
36. Ventura-Clapier R, Veksler V, Hoerter JA. 1994. Myofibrillar creatine kinase and cardiac contraction. Mol Cell Biochem 133-134:125-144.
37. Wieser W, Krumschnabel G. 2001. Hierarchies of ATP-consuming processes: direct compared with indirect measurements, and comparative aspects. Biochem J 355(Pt 2):389-395.
38. Yoshida M, Muneyuki E, Hisabori T. 2001. ATP synthase - a marvellous rotary engine of the cell. Nat Rev Mol Cell Biol 2:669-677.
39. Zhu D, Tan KS, Zhang X, Sun AY, Sun GY, Lee JC. 2005. Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci 118(Pt 16):3695-3703.